Form 8-K - Current report:
SEC Accession No. 0001104659-15-071102
Filing Date
2015-10-16
Accepted
2015-10-16 17:21:42
Documents
4
Period of Report
2015-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-16899_58k.htm 8-K 30585
2 EX-5.1 a15-16899_5ex5d1.htm EX-5.1 13041
3 EX-10.1 a15-16899_5ex10d1.htm EX-10.1 218947
4 GRAPHIC g168995kii001.jpg GRAPHIC 2682
  Complete submission text file 0001104659-15-071102.txt   267438
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 151162619
SIC: 2834 Pharmaceutical Preparations